These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 29487993)
1. Ablative dual-phase Erbium:YAG laser treatment of atrophy-related vaginal symptoms in post-menopausal breast cancer survivors omitting hormonal treatment. Mothes AR; Runnebaum M; Runnebaum IB J Cancer Res Clin Oncol; 2018 May; 144(5):955-960. PubMed ID: 29487993 [TBL] [Abstract][Full Text] [Related]
2. An innovative dual-phase protocol for pulsed ablative vaginal Erbium:YAG laser treatment of urogynecological symptoms. Mothes AR; Runnebaum M; Runnebaum IB Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():167-171. PubMed ID: 30199815 [TBL] [Abstract][Full Text] [Related]
3. Rationale and design for fractional microablative CO Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818 [TBL] [Abstract][Full Text] [Related]
4. Vaginal erbium laser as second-generation thermotherapy for the genitourinary syndrome of menopause: a pilot study in breast cancer survivors. Gambacciani M; Levancini M Menopause; 2017 Mar; 24(3):316-319. PubMed ID: 28231079 [TBL] [Abstract][Full Text] [Related]
5. Vaginal laser therapy for GSM/VVA: where we stand now - a review by the EUGA Working Group on Laser. Salvatore S; Ruffolo AF; Phillips C; Athanasiou S; Cardozo L; Serati M; Climacteric; 2023 Aug; 26(4):336-352. PubMed ID: 37395104 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause. Gaspar A; Brandi H; Gomez V; Luque D Lasers Surg Med; 2017 Feb; 49(2):160-168. PubMed ID: 27546524 [TBL] [Abstract][Full Text] [Related]
7. Histological findings after non-ablative Er:YAG laser therapy in women with severe vaginal atrophy. Gaspar A; Silva J; Calderon A; Di Placido V; Vizintin Z Climacteric; 2020; 23(sup1):S11-S13. PubMed ID: 33124455 [No Abstract] [Full Text] [Related]
8. Erbium laser in gynecology. Vizintin Z; Lukac M; Kazic M; Tettamanti M Climacteric; 2015; 18 Suppl 1():4-8. PubMed ID: 26366793 [TBL] [Abstract][Full Text] [Related]
9. Laser therapy for the restoration of vaginal function. Gambacciani M; Palacios S Maturitas; 2017 May; 99():10-15. PubMed ID: 28364861 [TBL] [Abstract][Full Text] [Related]
10. Intraurethral Erbium:YAG laser for the management of urinary symptoms of genitourinary syndrome of menopause: A pilot study. Gaspar A; Maestri S; Silva J; Brandi H; Luque D; Koron N; Vižintin Z Lasers Surg Med; 2018 Oct; 50(8):802-807. PubMed ID: 29667744 [TBL] [Abstract][Full Text] [Related]
11. Vulvo-vaginal atrophy: a new treatment modality using thermo-ablative fractional CO2 laser. Perino A; Calligaro A; Forlani F; Tiberio C; Cucinella G; Svelato A; Saitta S; Calagna G Maturitas; 2015 Mar; 80(3):296-301. PubMed ID: 25596815 [TBL] [Abstract][Full Text] [Related]
12. Genitourinary syndrome of menopause (GSM) and laser VEL: a review. Elia D; Gambacciani M; Berreni N; Bohbot JM; Druckmann R; Geoffrion H; Haab F; Heiss N; Rygaloff N; Russo E Horm Mol Biol Clin Investig; 2019 Dec; 41(1):. PubMed ID: 31855563 [TBL] [Abstract][Full Text] [Related]
13. Fractional CO2 laser therapy for genitourinary syndrome of menopause for breast cancer survivors. Quick AM; Zvinovski F; Hudson C; Hundley A; Evans C; Suresh A; Stephens JA; Arthur E; Ramaswamy B; Reinbolt RE; Noonan AM; VanDeusen JB; Wesolowski R; Stover DG; Williams NO; Sardesai SD; Smith KL; Faubion SS; Loprinzi CL; Lustberg MB Support Care Cancer; 2020 Aug; 28(8):3669-3677. PubMed ID: 31811486 [TBL] [Abstract][Full Text] [Related]
14. Non-ablative Er:YAG laser therapy effect on stress urinary incontinence related to quality of life and sexual function: A randomized controlled trial. Blaganje M; Šćepanović D; Žgur L; Verdenik I; Pajk F; Lukanović A Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():153-158. PubMed ID: 29604548 [TBL] [Abstract][Full Text] [Related]
15. Vaginal Er:YAG laser application in the menopausal ewe model: a randomised estrogen and sham-controlled trial. Mackova K; Mazzer AM; Mori Da Cunha M; Hajkova Hympanova L; Urbankova I; Kastelein AW; Vodegel E; Vander Linden K; Fehervary H; Guler Z; Roovers JP; Krofta L; Verhaeghe J; Deprest J BJOG; 2021 May; 128(6):1087-1096. PubMed ID: 33017509 [TBL] [Abstract][Full Text] [Related]
16. The ewe as an animal model of vaginal atrophy and vaginal Er:YAG laser application. Hympanova L; Rynkevic R; Mori Da Cunha MGMC; Diedrich CM; Blacher S; De Landsheere L; Mackova K; Krofta L; Roovers JP; Deprest J Menopause; 2020 Nov; 28(2):198-206. PubMed ID: 33235032 [TBL] [Abstract][Full Text] [Related]
17. The Impact of Vaginal Laser Treatment for Genitourinary Syndrome of Menopause in Breast Cancer Survivors: A Systematic Review and Meta-analysis. Jha S; Wyld L; Krishnaswamy PH Clin Breast Cancer; 2019 Aug; 19(4):e556-e562. PubMed ID: 31227415 [TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of non-ablative CO Lami A; Alvisi S; Baldassarre M; Zanella S; Amati V; Seracchioli R; Meriggiola MC Arch Gynecol Obstet; 2024 Apr; 309(4):1575-1583. PubMed ID: 38253692 [TBL] [Abstract][Full Text] [Related]
19. Can pelvic organ prolapse in postmenopausal women be treated with laser therapy? Athanasiou S; Pitsouni E; Cardozo L; Zacharakis D; Petrakis E; Loutradis D; Grigoriadis T Climacteric; 2021 Feb; 24(1):101-106. PubMed ID: 32720552 [TBL] [Abstract][Full Text] [Related]
20. The effect of vaginal erbium laser treatment on sexual function and vaginal health in women with a history of breast cancer and symptoms of the genitourinary syndrome of menopause: a prospective study. Arêas F; Valadares ALR; Conde DM; Costa-Paiva L Menopause; 2019 Sep; 26(9):1052-1058. PubMed ID: 31453969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]